Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,556.00    -63.00 (-2.41%)
Bid:
2,566.00
Ask:
2,569.00
Spread: 3.00 (0.117%)
Market Cap: £22.82b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Block listing Return

16 Jan 2026 11:41

RNS Number : 2707P
Experian plc
16 January 2026
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 16 January 2026

 

Name of applicant:

Experian plc

Name of scheme:

The Experian UK Tax-Qualified Sharesave Plan

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

833,612

 

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

81,305

 

Equals: Balance under scheme not yet issued/allotted at end of period:

752,307

 

 

Name of applicant:

Experian plc

Name of scheme:

The Experian International Sharesave Plan

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

771,564

 

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

98,000

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

75,907

 

Equals: Balance under scheme not yet issued/allotted at end of period:

793,657

 

 

 

Name of applicant:

Experian plc

Name of scheme:

The Experian Tax-Qualified Employee Share Purchase Plan

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

278,213

 

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

0

 

Equals: Balance under scheme not yet issued/allotted at end of period:

278,213

 

 

 

Name of applicant:

Experian plc

Name of scheme:

The Experian Irish Approved Sharesave Plan 

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

150,340

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

566

Equals: Balance under scheme not yet issued/allotted at end of period:

149,774

 

 

Name of contact:

Claire Murphy, Deputy Company Secretary, Experian plc

 

Telephone number of contact:

+353 (0) 87 118 4397

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRAKABBDBKDODD
Date   Source Headline
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20239:30 amRNSAdditional Listing
1st Feb 20239:15 amRNSAdditional Listing
31st Jan 20232:30 pmRNSDirector Declaration
31st Jan 202310:15 amRNSTotal Voting Rights
25th Jan 20239:15 amRNSAdditional Listing
17th Jan 20237:00 amRNSExperian Q3 FY23 trading update
13th Jan 20235:20 pmRNSFirst interim dividend
9th Jan 20237:00 amRNSDirectorate Change
30th Dec 202210:15 amRNSTotal Voting Rights
16th Dec 202211:30 amRNSElections for first interim dividend
14th Dec 20229:15 amRNSAdditional Listing
7th Dec 20229:00 amRNSAdditional Listing
30th Nov 202211:59 amRNSTotal Voting Rights
16th Nov 20227:00 amRNSHalf-year Report
31st Oct 20229:30 amRNSTotal Voting Rights
14th Oct 20229:51 amRNSShare Repurchase Programme
6th Oct 20227:00 amRNSDirectorate Change
5th Oct 20229:10 amRNSAdditional Listing
30th Sep 202212:06 pmRNSTotal Voting Rights
28th Sep 20229:02 amRNSAdditional Listing
19th Sep 202210:00 amRNSBlock listing Interim Review
14th Sep 20229:30 amRNSAdditional Listing
7th Sep 20229:30 amRNSAdditional Listing
31st Aug 202210:07 amRNSTotal Voting Rights
31st Aug 20229:30 amRNSAdditional Listing
17th Aug 20229:30 amRNSAdditional Listing
10th Aug 20229:15 amRNSAdditional Listing
29th Jul 20229:57 amRNSTotal Voting Rights
28th Jul 20229:25 amRNSDirector/PDMR Shareholding
21st Jul 202211:15 amRNSResult of AGM
21st Jul 202210:30 amRNSDirector Declaration
20th Jul 20229:30 amRNSAdditional Listing
14th Jul 20227:00 amRNSTrading update, first quarter
1st Jul 20225:42 pmRNSSecond Interim Dividend
30th Jun 20225:50 pmRNSTransaction in Own Shares
30th Jun 20224:00 pmRNSDirector/PDMR Shareholding
30th Jun 202210:54 amRNSTotal Voting Rights
29th Jun 20225:12 pmRNSTransaction in Own Shares
28th Jun 20225:28 pmRNSTransaction in Own Shares
27th Jun 20225:14 pmRNSTransaction in Own Shares
27th Jun 20222:15 pmRNSHolding(s) in Company
24th Jun 20225:41 pmRNSTransaction in Own Shares
24th Jun 202210:51 amRNSDirector/PDMR Shareholding
23rd Jun 20225:19 pmRNSTransaction in Own Shares
22nd Jun 20225:50 pmRNSTransaction in Own Shares
20th Jun 20225:26 pmRNSTransaction in Own Shares
17th Jun 20225:10 pmRNSTransaction in Own Shares
16th Jun 20225:33 pmRNSTransaction in Own Shares
15th Jun 20226:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.